MEI Pharma Inc
NASDAQ:MEIP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MEI Pharma Inc
NASDAQ:MEIP
|
US |
|
Safehold Inc
NYSE:SAFE
|
US |
|
Atos SE
PAR:ATO
|
FR |
|
W
|
West African Resources Ltd
F:W25
|
AU |
|
R
|
Ryder System Inc
F:RYD
|
US |
|
A
|
Abacus Mining and Exploration Corp
OTC:ABCFF
|
CA |
|
Avenue Supermarts Ltd
NSE:DMART
|
IN |
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MEIP's stock price target?
Not Available
MEIP does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for MEI Pharma Inc?
Projected CAGR
-27%
The compound annual growth rate for Revenue over the next 3 years is -27%.